A few molecular studies of CRCs and gastric cancers suggest that most HER2 amplified tumors were microsatellite stable (MSS), representing a negative correlation between HER2 amplification and MSI in gastrointestinal cancers8,9. Here, ERBB2 is linked to gastric cancer.